Mayer Emeran A, Labus Jennifer S, Tillisch Kirsten, Cole Steven W, Baldi Pierre
Department of Medicine, University of California at Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095-7378, USA.
Department of Medicine, University of California at Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095-7378, USA and West Los Angeles VA Medical Center, 11301 Wilshire Boulevard, Los Angeles, CA 90073, USA.
Nat Rev Gastroenterol Hepatol. 2015 Oct;12(10):592-605. doi: 10.1038/nrgastro.2015.121. Epub 2015 Aug 25.
Despite an extensive body of reported information about peripheral and central mechanisms involved in the pathophysiology of IBS symptoms, no comprehensive disease model has emerged that would guide the development of novel, effective therapies. In this Review, we will first describe novel insights into some key components of brain-gut interactions, starting with the emerging findings of distinct functional and structural brain signatures of IBS. We will then point out emerging correlations between these brain networks and genomic, gastrointestinal, immune and gut-microbiome-related parameters. We will incorporate this new information, as well as the reported extensive literature on various peripheral mechanisms, into a systems-based disease model of IBS, and discuss the implications of such a model for improved understanding of the disorder, and for the development of more-effective treatment approaches in the future.
Nat Rev Gastroenterol Hepatol. 2015-10
Mol Psychiatry. 2023-4
J Pediatr Gastroenterol Nutr. 2009-4
Curr Gastroenterol Rep. 2005-8
World J Gastroenterol. 2014-7-21
Am J Physiol Gastrointest Liver Physiol. 2016-11-1
J Gastroenterol Hepatol. 2011-4
World J Gastroenterol. 2015-10-28
World J Gastroenterol. 2022-3-28
Diagnostics (Basel). 2025-2-14
Biomolecules. 2024-12-21
Am J Physiol Gastrointest Liver Physiol. 2015-6-1
J Clin Invest. 2015-3-2
J Clin Invest. 2015-3-2
Br Med Bull. 2015-3
Gastroenterology. 2015-1-9
Aliment Pharmacol Ther. 2014-12-3